Physician profile
Timothy Talbert
NPI 1619966330
$7,639.05
in general payments reported to CMS, 2019-2025
32 companies · $344 in 2025
The $344 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $999 · 2020: $233 · 2021: $2,255 · 2022: $1,231 · 2023: $1,109 · 2024: $1,467 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046 · Travel and Lodging: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,045.76 |
| Travel and Lodging | $874.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $1,970.86 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro |
| Medtronic, INC. | $1,733.08 | 2021-2025 | Micra, Export Ap, Linq II |
| Abbott Laboratories | $949.39 | 2023-2025 | Aveir, Cardiomems, Diamondback Coronary |
| Stryker Corporation | $587.40 | 2019-2023 | Mako |
| Medical Device Business Services, INC. | $340.66 | 2021 | |
| Boston Scientific Corporation | $324.14 | 2019-2022 | |
| Atricure, INC. | $251.70 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $236.13 | 2019-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $204.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $184.91 | 2019-2024 | Xarelto |
| Pfizer INC. | $111.75 | 2019 | |
| Baxter Healthcare | $76.62 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $71.52 | 2020-2023 | |
| Irhythm Technologies, INC. | $70.95 | 2022-2024 | Zio Xt Patch |
| Shockwave Medical, INC | $59.86 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $48.69 | 2023-2024 | Rybelsus, Ozempic |
| Elutia, INC. | $39.38 | 2019-2021 | |
| Livanova USA, INC. | $38.27 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $37.56 | 2020-2022 | |
| Amgen INC. | $34.32 | 2019 | |
| Astellas Pharma US INC | $32.66 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.99 | 2019 | |
| Edwards Lifesciences Corporation | $28.29 | 2023 | Sapien 3 Ultra Resilia |
| Cardiva Medical, INC. | $28.22 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Innovation Technologies INC | $25.85 | 2025 | Irrisept |
| Cvrx, INC. | $21.30 | 2024 | Barostim Neo System |
| Genzyme Corporation | $21.15 | 2022 | |
| Lundbeck LLC | $19.12 | 2020 | |
| Abiomed | $18.05 | 2025 | |
| Esperion Therapeutics, INC. | $15.02 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.54 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Talbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.